Hainan Poly Pharm: Announcement by Zhongzheng Pengyuan on the delayed disclosure of Hainan Poly Pharm and related bonds' 2024 regular tracking rating report.
Pulley Pharmaceuticals: An indicative announcement on anticipating that convertible debt-to-equity conversion prices will trigger downward correction conditions
Pulley Pharmaceuticals: An indicative announcement on anticipating that convertible debt-to-equity conversion prices will trigger downward correction conditions
Pulley Pharmaceuticals: 2021 Annual Equity Distribution Implementation Notice
Pulley Pharmaceutical: 2021 Hainan Puli Pharmaceutical Co., Ltd. issued convertible corporate bonds to unspecified targets 2022 tracking rating report
Pulley Pharmaceuticals: Announcement on 2022 interest payments on convertible corporate bonds
Pulley Pharmaceuticals: Announcement on the reduction of convertible corporate bond holdings by controlling shareholders and co-actors
Pulley Pharmaceuticals: Announcement on the reduction of convertible corporate bond holdings by controlling shareholders and co-actors
Pulley Pharmaceuticals: Announcement on the controlling shareholder's holdings of convertible corporate bonds
Pulley Pharmaceuticals: Announcement on price adjustments for convertible corporate bonds to shares
Pulley Pharmaceuticals: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Pulley Pharmaceuticals: Responses from issuers and sponsors to the review enquiry letter (updated version of the 2020 Third Quarter Report)
Pulley Pharmaceuticals: Accountant's Response to the Audit Inquiry Letter (2020 Third Quarterly Report Updated Draft)
Pulley Pharmaceuticals: Supplemental Legal Opinion (2)
Pulley Pharmaceuticals: Accountant's Response to the Listing Committee's Review and Implementation Letter
Pulley Pharmaceuticals: Responses from issuers and sponsors to the implementation letter of the Listing Committee's review opinions
Pulley Pharmaceuticals: Announcement on the application for issuing convertible corporate bonds to unspecified targets and approved by the Shenzhen Stock Exchange GEM Listing Committee
Pulley Pharmaceutical: Implementation letter on the review opinions of the listing committee of Hainan Puli Pharmaceutical Co., Ltd.
Pulley Pharmaceuticals: Response of the Company and Haitong Securities Co., Ltd. to the audit inquiry letter on the company's application to issue convertible corporate bonds to unspecified targets
Pulley Pharmaceuticals: Accountant's Response to the Audit Enquiry Letter
No Data
No Data